Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Sep 28, 2022 $46.13 -0.11% $43.84 V 94.78% 1
Sep 28, 2022 $43.72 -5.32% $43.84 V 99.73% 5
Sep 28, 2022 $35.01 -24.19% $43.84 V 79.86% 1
Sep 28, 2022 Bullish $43.84 X 0
SonaCortado SonaCortado Merchant
Sep 23, 2022 $49.44 -3.17% $41.87 V 81.92% 1
JS JS Pro
Sep 23, 2022 $48.48 -5.05% $41.87 V 84.21% 1
Sep 23, 2022 $48.93 -4.17% $41.87 V 83.13% 1
Sep 23, 2022 $32.94 -35.48% $41.87 V 78.68% 1
AlexVel AlexVel Pro
Sep 23, 2022 $52.34 +2.51% $41.87 X 74.99% 0
Sep 23, 2022 Bullish $41.87 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE